E Fund Management Co., Ltd. Enanta Pharmaceuticals Inc Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$40.77 - $53.73 $489 - $644	-12 Reduced 0.27%	4,369 $203,000
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $93,634 - $138,192	-1,939 Reduced 30.68%	4,381 $227,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $130,785 - $263,869	3,430 Added 118.69%	6,320 $299,000
Q1 2022 May 12, 2022	BUY	$56.06 - $74.11 $82,352 - $108,867	1,469 Added 103.38%	2,890 $206,000
Q1 2021 May 12, 2021	BUY	$41.69 - $54.95 $59,241 - $78,083	1,421 New	1,421 $70,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.